Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).
about
Insulin sensitivity and complications in type 1 diabetes: New insightsThe Genetic Landscape of Renal Complications in Type 1 Diabetes.Heterogeneous behavior of lipids according to HbA1c levels undermines the plausibility of metabolic syndrome in type 1 diabetes: data from a nationwide multicenter survey.Adult stature and diabetes complications in patients with type 1 diabetes: the FinnDiane Study and the diabetes control and complications trial.Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction ruleThe cross-sectional associations between sense of coherence and diabetic microvascular complications, glycaemic control, and patients' conceptions of type 1 diabetesAssociations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional studyAssociation between testosterone, estradiol and sex hormone binding globulin levels in men with type 1 diabetes with nephropathy.Decline in the cumulative incidence of severe diabetic retinopathy in patients with type 1 diabetes.Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years.Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad.Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.Bacterial endotoxin activity in human serum is associated with dyslipidemia, insulin resistance, obesity, and chronic inflammation.Role of oxidative stress in endothelial insulin resistance.Progression to microalbuminuria in patients with type 1 diabetes: a seven-year prospective study.Predicting major outcomes in type 1 diabetes: a model development and validation studyInsulin resistance and associated factors in patients with Type 1 Diabetes.Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetesAge at menarche and the risk of diabetic microvascular complications in patients with type 1 diabetes.Liraglutide for treating type 1 diabetes.Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study.Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes.Sphingomyelin is associated with kidney disease in type 1 diabetes (The FinnDiane Study).Association testing of previously reported variants in a large case-control meta-analysis of diabetic nephropathy.Study of ambulatory blood pressure in diabetic children: prediction of early renal insultGenetic Evidence for a Causal Role of Obesity in Diabetic Kidney Disease.Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.Data-driven metabolic subtypes predict future adverse events in individuals with type 1 diabetes.Impact of Lifestyle Modification on Diabetic Kidney Disease1H NMR metabonomics approach to the disease continuum of diabetic complications and premature deathMechanisms of disease: Pathway-selective insulin resistance and microvascular complications of diabetes.Variation in SLC19A3 and Protection From Microvascular Damage in Type 1 Diabetes.Glomerular-specific protein kinase C-β-induced insulin receptor substrate-1 dysfunction and insulin resistance in rat models of diabetes and obesityInsulin: potential negative consequences of early routine use in patients with type 2 diabetes.Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetesG/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.
P2860
Q27000205-0B7592DF-D682-4723-863D-D6EA32C5B123Q30275890-2421F12F-4500-4FE1-B983-B735EEDD65A5Q30583410-58762FFF-B07D-4CFC-91B0-C2CA70FB264AQ33459001-7E78CD04-B2C2-4FA6-925C-0EBF7D5E45F0Q33555198-158F6016-2108-4633-A7A2-6FAE40696DF5Q33756811-8C010F51-3E83-4C43-B63D-3E21EBF11B8FQ33837711-2062F1E7-82CB-4048-982E-C9E60C4D80BDQ33940015-AC6A86F7-4060-46CC-98C7-1EDAB725747FQ34003238-0AF88DEE-00C3-4C92-AA5C-093D76A56BAEQ34084609-6FA8C9BB-DAF3-4CFB-8297-54AF09D06A2BQ34370502-A1F41835-7E08-4CB1-A86E-B230DC592C81Q34391710-2D692234-BFC3-40DF-9E0D-7A2990FA2DA3Q34595173-61FAAE23-2DAE-40E2-9DA5-CF7A849925B1Q34695419-4EA7FC19-50D3-4EEE-AC53-CAD2D758C097Q35123469-5AE9B322-5F8B-4509-AAAC-5DEBEDE14F09Q35179243-0EBD3CE7-3B2E-4226-9E3C-D0C5F0FA1E08Q35225575-E2707314-6FD2-46AA-9C92-C83426B90875Q35446651-15B86177-25F7-4396-A128-3DFE6F305D5AQ35559139-8EB2CFE9-E7B5-4987-B0EB-088127CC21BCQ35627229-9EE1BDC2-AC0C-4643-A848-A824677E7563Q35853037-80CEC269-CD7B-42DD-8EA8-A061897C87E4Q35939660-5CA6B0D9-5715-4410-B9FE-52AB0B4D1E16Q35943762-D92526AF-AA56-4238-8F4A-D1CA35ED78A8Q35950003-D324E786-CDA9-4D4B-B3A8-FAC652DA2600Q35957661-24CB3B38-CB75-41FB-A1D2-BC7B2FD27988Q36109264-ECD9833D-20A7-4278-B0BE-3DC49154D8BDQ36142155-B49F4ADC-FB32-4CC7-9531-9D73C20657DCQ36311567-375498B0-7D53-4E41-85D9-3CFB7DF0893AQ36332106-98BC05F9-A967-42F1-A828-5F654C584F7DQ36334563-C267A3A3-160D-4B34-BFB4-4C25439D1CCCQ36355894-552B099E-C128-4D50-8B2A-988478CB0058Q36458435-2E7C53D6-AF84-4718-80AF-F8B3F0D05375Q36496258-EA528AFC-0669-49C8-A582-C38E339FEC37Q36575450-F28B30CF-4557-414B-BADB-17922D1A38AFQ36725829-75337C4C-7968-42D7-A169-FA174F917B5EQ36730493-EAC00929-3EE1-4E8E-ACB6-42C07E7C6118Q36783839-DB82E1D0-CDEA-4887-BF77-114473E8A486Q36842641-B834D72C-69C0-450E-BDAE-099FE633B129Q36906421-50F50FA1-4C76-402E-A8C3-1CDD99921D7FQ36942114-23239D10-0720-4894-83A7-76B3FB705FB1
P2860
Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Metabolic syndrome in type 1 d ...... control (the FinnDiane study).
@en
Metabolic syndrome in type 1 d ...... phropathy and glycemic control
@nl
type
label
Metabolic syndrome in type 1 d ...... control (the FinnDiane study).
@en
Metabolic syndrome in type 1 d ...... phropathy and glycemic control
@nl
prefLabel
Metabolic syndrome in type 1 d ...... control (the FinnDiane study).
@en
Metabolic syndrome in type 1 d ...... phropathy and glycemic control
@nl
P2093
P50
P1433
P1476
Metabolic syndrome in type 1 d ...... control (the FinnDiane study).
@en
P2093
Clas-Göran Af Björkesten
Johan Fagerudd
Johan Wadén
Kim Pettersson-Fernholm
Markku Saraheimo
Mats Rönnback
P304
P356
10.2337/DIACARE.28.8.2019
P407
P50
P577
2005-08-01T00:00:00Z